PEGASYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PEGASYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $204.36M | Feb 25, 2016 |
| FY2015 | Sep 30, 2015 | $162.40M | Feb 25, 2016 |
| FY2015 | Jun 30, 2015 | $162.02M | Feb 25, 2016 |
| FY2015 | Mar 31, 2015 | $153.92M | Feb 25, 2016 |
| FY2015 | Dec 31, 2014 | $168.92M | Feb 25, 2016 |
| FY2015 | Sep 30, 2014 | $137.63M | Feb 25, 2016 |
| FY2015 | Jun 30, 2014 | $142.99M | Feb 25, 2016 |
| FY2015 | Mar 31, 2014 | $140.46M | Feb 25, 2016 |
| FY2013 | Dec 31, 2013 | $153.38M | Feb 25, 2014 |
| FY2014 | Sep 30, 2013 | $122.01M | Feb 26, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.75B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.50B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.43B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $1.32B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.21B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $1.02B | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $276.54M | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | $216.70M | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | $205.59M | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | $212.55M | Feb 12, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $239.54M | Feb 26, 2018 |
| FY2017 | Sep 30, 2017 | $179.82M | Feb 26, 2018 |
| FY2017 | Jun 30, 2017 | $197.98M | Feb 26, 2018 |
| FY2017 | Mar 31, 2017 | $223.25M | Feb 26, 2018 |
| FY2017 | Dec 31, 2016 | $199.61M | Feb 26, 2018 |
| FY2017 | Sep 30, 2016 | $182.80M | Feb 26, 2018 |
| FY2017 | Jun 30, 2016 | $189.00M | Feb 26, 2018 |
| FY2017 | Mar 31, 2016 | $178.86M | Feb 26, 2018 |
| FY2016 | Dec 31, 2015 | $204.36M | Feb 24, 2017 |
| FY2016 | Sep 30, 2015 | $162.40M | Feb 24, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.32B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.11B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.05B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $949.21M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $875.29M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $706.60M | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $198.94M | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | $135.81M | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | $128.51M | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | $138.11M | Feb 12, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $393.44M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $99.19M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $67.81M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | ($345.58M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | ($63.04M) | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | ($61.37M) | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $918.0K | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | ($30.34M) | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | ($32.30M) | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | ($28.72M) | Feb 12, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $263.10M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $123.88M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $80.95M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | ($109.41M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | ($94.73M) | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | ($143.53M) | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | ($1.75M) | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | ($46.77M) | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | ($52.34M) | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | ($34.03M) | Feb 12, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $312.68M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $298.07M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $295.51M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $294.35M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $260.63M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $236.99M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $205.21M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $181.71M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $162.89M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $145.55M | Feb 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $505.23M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $345.93M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $217.79M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $22.34M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $39.12M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | ($563.0K) | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | ($42.17M) | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $104.36M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $158.24M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $39.87M | Feb 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.50M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $7.71M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $16.78M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $35.38M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $10.46M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $25.37M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $10.61M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $11.89M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $13.74M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $19.09M | Feb 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.63B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.77B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $1.51B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.36B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $1.59B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.60B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $984.81M | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $982.55M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $1.01B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $654.66M | Feb 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $844.46M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $1.16B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.23B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $1.18B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.06B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $445.80M | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $361.02M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $356.88M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $318.77M | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $787.38M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $585.48M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $353.84M | Feb 10, 2026 |
| FY2025 | Dec 31, 2022 | $130.84M | Feb 10, 2026 |
| FY2024 | Dec 31, 2021 | $416.09M | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $542.17M | Feb 14, 2024 |
| FY2022 | Dec 31, 2019 | $539.01M | Feb 15, 2023 |
| FY2021 | Dec 31, 2018 | $621.53M | Feb 16, 2022 |
| FY2020 | Dec 31, 2017 | $655.87M | Feb 17, 2021 |
| FY2019 | Dec 31, 2016 | $548.94M | Feb 12, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.51M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $81.11M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $81.61M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $81.40M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $81.92M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $79.23M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $79.04M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $72.86M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $72.95M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $73.16M | Feb 20, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $463.39M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $87.90M | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | ($8.71M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | ($76.51M) | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $276.45M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $339.88M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $410.92M | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $510.86M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $509.70M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $198.32M | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $212.45M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $337.10M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $229.90M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $145.05M | Feb 12, 2025 |
| FY2022 | Dec 31, 2021 | $159.97M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $171.90M | Feb 16, 2022 |
| FY2018 | Dec 31, 2018 | $114.42M | Feb 20, 2019 |
| FY2018 | Dec 31, 2017 | $162.28M | Feb 20, 2019 |
| FY2018 | Dec 31, 2016 | $70.59M | Feb 20, 2019 |
| FY2018 | Dec 31, 2015 | $93.03M | Feb 20, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | (4) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 12, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | (4) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 12, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 170.35M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 172.22M | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | 83.84M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 82.44M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | 81.71M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | 80.89M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | 79.60M | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | 78.53M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | 78.08M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | 76.59M | Feb 26, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.42M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $10.20M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $9.96M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $9.83M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $9.76M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $9.63M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $9.49M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $9.43M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $9.28M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $9.17M | Feb 20, 2019 |